1. Home
  2. ATYR vs DRDB Comparison

ATYR vs DRDB Comparison

Compare ATYR & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.92

Market Cap

82.6M

Sector

Health Care

ML Signal

HOLD

DRDB

Roman DBDR Acquisition Corp. II Ordinary shares

N/A

Current Price

$10.52

Market Cap

320.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ATYR
DRDB
Founded
2005
2024
Country
United States
United States
Employees
58
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.6M
320.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
DRDB
Price
$0.92
$10.52
Analyst Decision
Hold
Analyst Count
9
0
Target Price
$3.67
N/A
AVG Volume (30 Days)
957.5K
213.3K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$597.54
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$10.16
52 Week High
$7.29
$10.55

Technical Indicators

Market Signals
Indicator
ATYR
DRDB
Relative Strength Index (RSI) 57.72 59.74
Support Level $0.68 $10.50
Resistance Level $1.12 $10.55
Average True Range (ATR) 0.06 0.01
MACD 0.02 -0.00
Stochastic Oscillator 57.49 66.67

Price Performance

Historical Comparison
ATYR
DRDB

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

About DRDB Roman DBDR Acquisition Corp. II Ordinary shares

Roman DBDR Acquisition Corp II is a blank check company.

Share on Social Networks: